|
Lipids and Lipid Disorders
Citations 191-200 of 264 total displayed.
|
Past content
(since Feb 1998):
|
- Letters
Long-term Cardiovascular Consequences of Diuretics vs Calcium Channel Blockers vs Angiotensin-Converting Enzyme Inhibitors
- Franz H. Messerli; Michael A. Weber
JAMA 2003; 289: 2067-2068.
[Extract]
[Full text]
[PDF]
- Letters
Long-term Cardiovascular Consequences of Diuretics vs Calcium Channel Blockers vs Angiotensin-Converting Enzyme Inhibitors
- Steven A. Yarows
JAMA 2003; 289: 2068-b-2069-b.
[Extract]
[Full text]
[PDF]
- Letters
Long-term Cardiovascular Consequences of Diuretics vs Calcium Channel Blockers vs Angiotensin-Converting Enzyme Inhibitors
- H. T. Ong
JAMA 2003; 289: 2068-a.
[Extract]
[Full text]
[PDF]
- Letters
Long-term Cardiovascular Consequences of Diuretics vs Calcium Channel Blockers vs Angiotensin-Converting Enzyme Inhibitors
- William Rifkin
JAMA 2003; 289: 2068.
[Extract]
[Full text]
[PDF]
- Letters
Long-term Cardiovascular Consequences of Diuretics vs Calcium Channel Blockers vs Angiotensin-Converting Enzyme Inhibitors—Reply
- Jackson T. Wright Jr; Barry R. Davis; Jeffrey A. Cutler
JAMA 2003; 289: 2069-2070.
[Extract]
[Full text]
[PDF]
- Letters
Lipid-Lowering Therapy and Risk of Coronary Events
- John A. Blakely
JAMA 2003; 289: 2070-a-2071-a.
[Extract]
[Full text]
[PDF]
- Letters
Lipid-Lowering Therapy and Risk of Coronary Events
- William C. Taylor
JAMA 2003; 289: 2070.
[Extract]
[Full text]
[PDF]
- Letters
Lipid-Lowering Therapy and Risk of Coronary Events—Reply
- Jeffrey L. Probstfield
JAMA 2003; 289: 2071-b-2072-b.
[Extract]
[Full text]
[PDF]
- Letters
Lipid-Lowering Therapy and Risk of Coronary Events
- Claude K. Lardinois
JAMA 2003; 289: 2071-a.
[Extract]
[Full text]
[PDF]
- Letters
Lipid-Lowering Therapy and Risk of Coronary Events
- Luca Mascitelli; Francesca Pezzetta
JAMA 2003; 289: 2071.
[Extract]
[Full text]
[PDF]
|
|
